Access Pharmaceuticals Presents New Data on the Company's Cobalamin(TM) Technology at an International Polymer Therapeutics...(nd operations and to the risksdetailed i...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Access Pharmaceuticals Presents New Data on the Company's Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium
Date:5/28/2008
nd operations and to the risks detailed in Access' Annual Report on Form 10-K and other reports filed by Access with the Securities and Exchange Commission.
'/>"/>
| SOURCE Access Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine technology :
1. IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
2. Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing
3. IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study
4. Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
5. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
6. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
7. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
10. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
11. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
Post Your Comments:
(Date:11/25/2009)...irstCall/--Hologic,Inc.(HologicortheCompany)(Nasda...rofpremiumdiagnostics,medicalimagingsystemsandsurg...women,isusingtheannualmeetingoftheRadiologicalSoci...ovember29throughDecember3,2009tohighlightournewSec...workstationsoftware. ,, TheHologicSecurViewwork...
(Date:11/25/2009)...TrendsResearchGroup,Inc.releasedWave1ofits Launch...asesyndicatedmarketresearchprojecttrackingthelaunc...hthroughthefirstsixmonthsofavailability.Eachwaveof...ueDermatologistsandqualitativeinformationfromasubs...lestouse,typicalpatienttypes,productperceptions,pr...
(Date:11/25/2009)...swire/--AMPACFineChemicalsLLC(AFC),asubsidiaryofAm...daythatitreceivedtheEnvironmentalResponsibilityand...alSummit,sponsoredbytheCaliforniaManufacturersandT...talAssociation(IEA)andtheChemicalIndustryCouncilof...giousawardavailablefromallthreeorganizationsandgai...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2McGill JGH researchers successfully reverse multiple sclerosis in animals 9531 1McGill JGH researchers successfully reverse multiple sclerosis in animals 9531 2Partnership to Fight Chronic Disease Analyzes Key Provisions in Health Care Legislation Released To Date 54208 1Partnership to Fight Chronic Disease Analyzes Key Provisions in Health Care Legislation Released To Date 54208 2Hospira Launches Generic Oxaliplatin Injection 54204 1Hospira Launches Generic Oxaliplatin Injection 54204 2Hospira Launches Generic Oxaliplatin Injection 54204 3[0] New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity[0] Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High[0] AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit
..., June 3 Delcath Systems, Inc.,(Nasdaq: DCTH ) a...f,Bethlehem, PA, part of St. Luke,s Hospital & Hea...e III clinical trial for the treatment of,inoperab...any,s,Percutaneous Hepatic Perfusion (PHP) System ...ancer agent melphalan. This Phase III multi-center...
...boomers age drug-free treatments receive renewed a...D, FACS, FAAP to begin Plantar ...BioElectronics Corp.,(BIEL), the maker of the Acti...th an embedded battery operated microchip deliveri... to speed healing, today announced that,recent sal...
Other Medicine Technology:Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center 2Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center 3BioElectronics Announces Profitability Breakeven and Additional Clinical Trials 2BioElectronics Announces Profitability Breakeven and Additional Clinical Trials 3BioElectronics Announces Profitability Breakeven and Additional Clinical Trials 4BioElectronics Announces Profitability Breakeven and Additional Clinical Trials 5(Date:11/25/2009)...ERYVILLE,Calif.,Nov.25/PRNewswire-FirstCall/-- On...dthatthecompanywillhosttwoinvestoreventsinDecember...0a.m.CT/10:00a.m.ET ,, Principalinvestigators...inrelapsedand/orrefractorymultiplemyeloma,asfeatur...eetingandExpositioninNewOrleans,LA.Theteleconferen...
(Date:11/25/2009)...RONTO,Nov.25/PRNewswire/-SentinelleMedicalInc.,ale...izationsoftwarelaunchesasuiteofnewleadingedgeclini...eplatformatthisyear,sRadiologicalSocietyofNorthAme...(Booth5800,HallA).Theapplicationsleveragetheunique...dMRIimagingcoilsandsupportmultipleimagingmodalitie...
(Date:11/25/2009)...LVERSPRING,Md.,Nov.25/PRNewswire-USNewswire/--Anar...forDrugEvaluationandResearch,titled"ADifficultBala...theNov.26,2009issueofTheNewEnglandJournalofMedicin...h/20090824/FDALOGO ) ,, Inthearticle,Woodcockdi...inmedicationforthosewhoneeditandmanagingtheriskspo...
(Date:11/25/2009)...NFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQualit...r Spare the Air Alert forThursday,No...logsoranyothersolidfuel,bothindoorsandoutdoors. ,...qualitytomorrow,"saidJackBroadbent,executiveoffice...spectthehealthoftheirneighborsandfellowcommunityme...
(Date:11/25/2009)...m survivors of testicular cancer who were treated ...side effects, including neurological side effects ...treated with chemotherapy, according to a new stud...the National Cancer Institute . , Marianne Brydy...niversity Hospital, in Bergen, Norway, and colleag...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2[0] Onyx Pharmaceuticals Announces December 2009 Investor Events[1] Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology[1] FDA's Woodcock Discusses Pain Management and Drug Safety in Nov. 26, 2009 Issue of The New England Journal of Medicine[0] Winter Spare the Air Alert in Effect for Thursday, November 26, 2009[0] News brief: Long-term testicular cancer survivors at high risk for neurological side effects
...sophageal reflux disease (GERD) is a common disord...%. The diagnosis and treatment of GERD are therefo...he highly disturbing typical symptoms, has a serie...carcinoma. , Although many investigators have rep...
... rinse of the airway beats saline sprays at provid...ay News) -- Saline irrigation is a safe, inexpensi... and sinus symptoms, according to a new study. , ...ure -- is more effective than commonly used saline...
... Iceland, Nov. 23 deCODE genetics,(Nasdaq: DCGN ... of deCODE,CEO Kari Stefansson,s presentation at t...he presentation will be delivered at 9:00 am EST o...code.com, and those,interested in listening shoul...
...ed water could boost child,s cancer risk, study fi... of women exposed to arsenic-contaminated water du...ay result in cancer and other diseases later in li...changes caused by prenatal exposure to an environm...
... revealing how berry helps ward off infection , TH...on your Thanksgiving dinner plate may be more than...o, scientists say. , Compounds in cranberries may ...decay -- say researchers at Worcester Polytechnic ...
...D, Calif. - Researchers at the Stanford University...cant step, in mouse studies, toward the goal of tr...e system for people with autoimmune or genetic blo...e systems. Many aspects of the technique would nee...
Other Medicine News:Health News:Saline Irrigation Eases Chronic Nasal Symptoms 2Health News:Cranberry Sauce May Be Healthy Treat 2Health News:Stem cell transplant can grow new immune system in certain mice, Stanford researchers find 2Age, burden, divorce and heavy tea consumption are significant risk factors for erosive esophagitisSaline Irrigation Eases Chronic Nasal SymptomsdeCODE genetics to Webcast Presentation at Piper Jaffray Annual Healthcare ConferenceFetal Exposure to Arsenic Affects GenesCranberry Sauce May Be Healthy TreatStem cell transplant can grow new immune system in certain mice, Stanford researchers find
AGIT1006 Agitator
Horizon Series Platelet Agitator PF48h
Horizon Series Platelet Agitator PF15h
...rs offer a wide range of storage capacities. Delri...form to agitate smoothly, eliminating the need for... one-piece perforated drawers with non-slip textur...r platelets., ,i.Series platelet agitators fea...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |